PTH Receptor Signaling in Osteocytes Governs Periosteal Bone Formation and Intracortical Remodeling

被引:174
作者
Rhee, Yumie [1 ]
Allen, Matthew R. [1 ]
Condon, Keith [1 ]
Lezcano, Virginia [1 ]
Ronda, Ana C. [1 ]
Galli, Carlo [1 ]
Olivos, Naomi [1 ]
Passeri, Giovanni [1 ]
O'Brien, Charles A. [2 ]
Bivi, Nicoletta [1 ]
Plotkin, Lilian I. [1 ]
Bellido, Teresita [1 ,3 ]
机构
[1] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Div Endocrinol, Indianapolis, IN 46202 USA
[2] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Dept Med, Div Endocrinol, Little Rock, AR 72205 USA
[3] Indiana Univ, Sch Med, Div Endocrinol, Dept Med, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
OSTEOCYTES; PTH RECEPTOR; PERIOSTEAL BONE FORMATION; WNT SIGNALING; INTRACORTICAL REMODELING; QUANTITATIVE COMPUTED-TOMOGRAPHY; PARATHYROID-HORMONE; CORTICAL BONE; PRIMARY HYPERPARATHYROIDISM; INTERMITTENT PTH; ILIAC CREST; IN-VIVO; SCLEROSTIN; OSTEOBLASTS; EXPRESSION;
D O I
10.1002/jbmr.304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The periosteal and endocortical surfaces of cortical bone dictate the geometry and overall mechanical properties of bone. Yet the cellular and molecular mechanisms that regulate activity on these surfaces are far from being understood. Parathyroid hormone (PTH) has profound effects in cortical bone, stimulating periosteal expansion and at the same time accelerating intracortical bone remodeling. We report herein that transgenic mice expressing a constitutive active PTH receptor in osteocytes (DMP1-caPTHR1 mice) exhibit increased cortical bone area and an elevated rate of periosteal and endocortical bone formation. In addition, DMP1-caPTHR1 mice display a marked increase in intracortical remodeling and cortical porosity. Crossing DMP1-caPTHR1 mice with mice lacking the Wnt coreceptor, LDL-related receptor 5 (LRP5), or with mice overexpressing the Wnt antagonist Sost in osteocytes (DMP1-Sost mice) reduced or abolished, respectively, the increased cortical bone area, periosteal bone formation rate, and expression of osteoblast markers and Wnt target genes exhibited by the DMP1-caPTHR1 mice. In addition, DMP1-caPTHR1 lacking LRP5 or double transgenic DMP1-caPTHR1; DMP1-Sost mice exhibit exacerbated intracortical remodeling and increased osteoclast numbers, and markedly decreased expression of the RANK decoy receptor osteoprotegerin. Thus, whereas Sost downregulation and the consequent Wnt activation is required for the stimulatory effect of PTH receptor signaling on periosteal bone formation, the Wnt-independent increase in osteoclastogenesis induced by PTH receptor activation in osteocytes overrides the effect on Sost. These findings demonstrate that PTH receptor signaling influences cortical bone through actions on osteocytes and defines the role of Wnt signaling in PTH receptor action. (C) 2011 American Society for Bone and Mineral Research.
引用
收藏
页码:1035 / 1046
页数:12
相关论文
共 50 条
[1]   Bone loss and bone size after menopause [J].
Ahlborg, HG ;
Johnell, O ;
Turner, CH ;
Rannevik, G ;
Karlsson, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :327-334
[2]   Periosteum: biology, regulation, and response to osteoporosis therapies [J].
Allen, MR ;
Hock, JM ;
Burr, DB .
BONE, 2004, 35 (05) :1003-1012
[3]   Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton [J].
Baron, Roland ;
Rawadi, Georges .
ENDOCRINOLOGY, 2007, 148 (06) :2635-2643
[4]   SEX-DIFFERENCES IN GEOMETRY OF THE FEMORAL-NECK WITH AGING - A STRUCTURAL-ANALYSIS OF BONE-MINERAL DATA [J].
BECK, TJ ;
RUFF, CB ;
SCOTT, WW ;
PLATO, CC ;
TOBIN, JD ;
QUAN, CA .
CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (01) :24-29
[5]   Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts - A putative explanation for why intermittent administration is needed for bone anabolism [J].
Bellido, T ;
Ali, AA ;
Plotkin, LI ;
Fu, Q ;
Gubrij, I ;
Roberson, PK ;
Weinstein, RS ;
O'Brien, CA ;
Manolagas, SC ;
Jilka, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50259-50272
[6]   Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis [J].
Bellido, T ;
Ali, AA ;
Gubrij, I ;
Plotkin, LI ;
Fu, Q ;
O'Brien, CA ;
Manolagas, SC ;
Jilka, RL .
ENDOCRINOLOGY, 2005, 146 (11) :4577-4583
[7]   Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone [J].
Bikle, DD ;
Sakata, T ;
Leary, C ;
Elalieh, H ;
Ginzinger, D ;
Rosen, CJ ;
Beamer, W ;
Majumdar, S ;
Halloran, BP .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (09) :1570-1578
[8]   Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys [J].
Burr, DB ;
Hirano, T ;
Turner, CH ;
Hotchkiss, C ;
Brommage, R ;
Hock, JM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) :157-165
[9]   Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone [J].
Calvi, LM ;
Sims, NA ;
Hunzelman, JL ;
Knight, MC ;
Giovannetti, A ;
Saxton, JM ;
Kronenberg, HM ;
Baron, R ;
Schipani, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :277-286
[10]   Constitutively active PTH/PTHrP receptor in odontoblasts alters odontoblast and ameloblast function and maturation [J].
Calvi, LM ;
Shin, HI ;
Knight, MC ;
Weber, JM ;
Young, MF ;
Giovannetti, A ;
Schipani, E .
MECHANISMS OF DEVELOPMENT, 2004, 121 (04) :397-408